265 related articles for article (PubMed ID: 16179938)
1. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
[TBL] [Abstract][Full Text] [Related]
2. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Mol Histol; 2006 Sep; 37(5-7):183-8. PubMed ID: 17048076
[TBL] [Abstract][Full Text] [Related]
3. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
[TBL] [Abstract][Full Text] [Related]
4. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
5. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.
Mazzarelli P; Pucci S; Spagnoli LG
Adv Cancer Res; 2009; 105():45-61. PubMed ID: 19879422
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
Park J; Park SY; Shin E; Lee SH; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kim H; Choi WS
Mol Cells; 2014 Feb; 37(2):178-86. PubMed ID: 24599003
[TBL] [Abstract][Full Text] [Related]
7. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
[TBL] [Abstract][Full Text] [Related]
8. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.
Rizzi F; Caccamo AE; Belloni L; Bettuzzi S
J Cell Physiol; 2009 May; 219(2):314-23. PubMed ID: 19137541
[TBL] [Abstract][Full Text] [Related]
9. The clusterin paradigm in prostate and breast carcinogenesis.
Rizzi F; Bettuzzi S
Endocr Relat Cancer; 2010 Mar; 17(1):R1-17. PubMed ID: 19903745
[TBL] [Abstract][Full Text] [Related]
10. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.
Leskov KS; Araki S; Lavik JP; Gomez JA; Gama V; Gonos ES; Trougakos IP; Matsuyama S; Boothman DA
J Biol Chem; 2011 Nov; 286(46):40083-90. PubMed ID: 21953454
[TBL] [Abstract][Full Text] [Related]
11. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.
Klokov D; Criswell T; Leskov KS; Araki S; Mayo L; Boothman DA
Mutat Res; 2004 Dec; 568(1):97-110. PubMed ID: 15530543
[TBL] [Abstract][Full Text] [Related]
12. Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B; Orzechowski A
Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
[TBL] [Abstract][Full Text] [Related]
13. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
[TBL] [Abstract][Full Text] [Related]
14. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
15. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
Redondo M; Tellez T; Roldan MJ
Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
[TBL] [Abstract][Full Text] [Related]
16. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269
[TBL] [Abstract][Full Text] [Related]
17. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
Kadam R; Harish M; Dalvi K; Teni T
Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
[TBL] [Abstract][Full Text] [Related]
18. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
19. Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro.
Shannan B; Seifert M; Leskov K; Boothman D; Pföhler C; Tilgen W; Reichrath J
Anticancer Res; 2006; 26(4A):2707-16. PubMed ID: 16886681
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of CLU isoforms in endometrial proliferative diseases.
Fuzio P; Valletti A; Napoli A; Napoli G; Cormio G; Selvaggi L; Liuni S; Pesole G; Maiorano E; Perlino E
Int J Oncol; 2013 Jun; 42(6):1929-44. PubMed ID: 23589125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]